24 Cent Micro Cap May Hold The Key To Potential Breakthrough In Acute Spinal Cord Injury
An estimated 250,000-500,000 people experience a %SpinalCordInjury (SCI) annually, with roughly 17,000 new cases in the US and 27,000 in Europe each year, leaving many of those people permanently confined...
Capricor (CAPR) Upgraded to Buy: What Does It Mean for the Stock?
Capricor (CAPR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Capricor Therapeutics (CAPR) Reports Q3 Loss, Tops Revenue Estimates
Capricor (CAPR) delivered earnings and revenue surprises of 7.14% and 279.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Capricor Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
-First Patient Treated in HOPE-3, the Pivotal Phase 3 Clinical Trial of CAP-1002 in Duchenne Muscular Dystrophy- -Positive One-Year...